Disease and Therapy Review: Systemic Lupus ErythematosusTimely Data Resources, Inc.September 1, 2009 8 Pages - SKU: TDR2428147 |
| Countries covered: Global The Systemic Lupus Erythematosus Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, with a disease overview. Treatment and dosing information for the various types of treatment options are discussed. Average annual treatment costs and market size estimates are also provided. |
Additional Information
The Lupus Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide. Information on diagnosis and treatment are provided, as well as treatment and dosing costs of lupus drugs. General information on the lupus market, as well as sales of leading drugs and therapies are provided.
More Global Women's Health Reports
Endometriosis by
Global Industry Analysts
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest ...
Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 by
GlobalData
Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global ...
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health by
Spectra Intelligence
The current market for hormonal contraceptives and infertility drugs is estimated at US$9.4bn, and is forecast to increase by 7% in annual revenues to US$10bn ...
Endometriosis by
Global Industry Analysts
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest ...
Women's Health Review and Outlook 2011 by
PharmaLive Special Reports
The global women's health market, valued at $20 billion in 2009, is dominated by the United States. Hormonal contraceptives is one of the leading categories ...
See all reports like this >>
Related Markets
- Diseases & Conditions
- Autoimmune
- Pharmaceuticals
- Research & Development
- Therapeutic Area
- Women's Health
Women's Health Reports
- Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors

